New comprehensive report on pediatric long COVID symptoms published

Up to 5.8 million children and youth in the U.S. have experienced symptoms of COVID-19 that persisted long after initial infection.

Ambitious federal study failed to curb opioid deaths, NIH announces

In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities

June 16, 2024

FDA advisory committee will meet next month to discuss Intarcia’s diabetes drug

An FDA advisory committee will meet on Sept. 21 to discuss Intarcia’s twice-rejected type 2 diabetes drug candidate and delivery system. The meeting comes nearly

August 24, 2023

New two-dose HIV vaccine strategy shows promise for stronger immune response

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.